Bone Marrow Characteristics Associated with Changes in Infarct Size after STEMI: A Biorepository Evaluation from the CCTRN TIME Trial

RATIONALE: Despite significant interest in bone marrow mononuclear cell (BMC) therapy for ischemic heart disease, current techniques have resulted in only modest benefits. However, select patients have shown improvements after autologous BMC therapy, but the contributing factors are unclear. OBJECTI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Res
Main Authors: Schutt, Robert C., Trachtenberg, Barry H., Cooke, John P., Traverse, Jay H., Henry, Timothy D., Pepine, Carl J., Willerson, James T., Perin, Emerson C., Ellis, Stephen G., Zhao, David X. M., Bhatnagar, Aruni, Johnstone, Brian H., Lai, Dejian, Resende, Micheline, Ebert, Ray F., Wu, Joseph C., Sayre, Shelly L., Orozco, Aaron, Zierold, Claudia, Simari, Robert D., Moyé, Lem, Cogle, Christopher R., Taylor, Doris A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282599/
https://ncbi.nlm.nih.gov/pubmed/25406300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.116.304710
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados